Record Quarter Meets Debt Reckoning: A Hold Until Leverage Clears

On the surface, a 37.8% OPM is exceptional — and it is. But the margin narrative must be disaggregated: Lloyds has delivered real structural tailwinds (slurry pipeline ₹550/ton cost save, BHQ beneficiation yield beat to 38% recovery, second pellet plant 100% capacity in 4 months), but this quarter's realization also rode commodity pricing tailwinds (iron ore ₹6,068/ton realization, pellet export premium, Thriveni new Odisha contracts at 40%+ EBITDA margins). The honest read: sustainability depends on whether the commodity cycle holds and whether the structured mix (25% pellet export, 75% domestic, internal ore consumption rerouted to value-added products) can defend margins in a softer price environment.

Capex guidance softened and spread. Prior ₹15,000 Cr FY27 → ₹11–11.5k Cr FY27, then ₹11–11.5k each FY28–29, then ₹15–20k FY30. Steel plant capex shifted to FY29 ramp, decelerating near-term deleveraging. Consolidated debt overshoot. Prior guidance 1–1.5x net debt/EBITDA; delivered 3.5x (₹19,000 Cr Chemaf overhang). Restructuring to cut 40–50% but timeline Q3 FY27, not immediate. Production targets tracking below guidance. Pellets annualize ~6.8M vs 8M (85% of target); DRI annualizes ~736k vs 825k (89%). Acceleration needed H2 FY27 or revisions likely. Wire rod entry deferred. Prior 150k tons FY27 no longer mentioned; steel plant (1.2M tons by Mar '27) is the only production detail. Wire rod launch absorbed into larger capacity roadmap, timeline unclear. BHQ yield beat. Recovery confirmed 38% vs 35% original; grade 66–67% Fe vs target. On-time commissioning Mar '28, cost in budget — a genuine operational win. Thriveni EBITDA margin hold firm. Q1 24.63% margin (+827 bps YoY); fuel cost pressure acknowledged, but FY27 28–30% guidance reaffirmed. New Odisha contracts (Laserda, Dalpahar) at 40%+ margins underpinning the target.

The post-result price action tells the story: day 1 down 3.24%, day 3 down 7.52%. The pop didn't hold. Lloyds is now at ₹1,942, down 8.61% from its all-time high of ₹2,125, but still up 86.21% off the 52-week low of ₹1,042.90 — a stock in the top half of its range but losing momentum. RSI 46.3 is neutral, neither overbought nor oversold. Institutional flows: FII trimmed their stake by 41 bps QoQ (1.85% now vs 2.26% in Q4 FY26); DII added 49 bps (2.19% now vs 1.70%); promoter steady at 61.63%. The foreign selling into the record quarter is notable — it signals skepticism that this margin/growth dynamic is sustainable. Domestic investors (DII) are buying the dip. Day-1 delivery of 51.4% (institutional participation) confirms that smart money was watching, but the lack of follow-through (day 3 down 7.5%) suggests the debt overshoot and capex spread outweighed the operational beat. The street's verdict: near-term execution is solid, but the debt path and margin sustainability are not yet credible.

1. H2 FY27 margin trajectory. Q1 37.8% OPM was exceptional. If Q2–Q4 margins hold above 35% EBITDA margin, the structural thesis (slurry, BHQ, product mix) holds water. If they compress below 32%, the cyclical thesis (commodity peak) wins and guidance cuts likely. 2. Chemaf restructuring update. Q3 FY27 financial closure is the stated target. Any slippage beyond Q3 or cut size lower than 40% signals leverage management challenges. This is the credibility gating item for the bull case. 3. FY27 pellet/DRI production tracking. Q1 annualizes 6.8M pellets (vs 8M), 736k DRI (vs 825k). Need H2 to show acceleration or management will revise full-year guidance down. If revised, confidence in capex roadmap wanes.